| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.685 | 0.005 | 0.685 | DNA synthesis inhibitor | 0.546 0.01 CID_3385 | ||
| 0.5 | 0.004 | 0.5 | DNA directed RNA polymerase inhibitor | 0.189 0.015 CID_3385 | ||
| 0.505 | 0.01 | 0.505 | RNA-directed DNA polymerase inhibitor | 0.347 0.024 CID_3385 | ||
| 0.465 | 0.007 | 0.465 | Cytidine deaminase inhibitor | 0.261 0.027 CID_3385 | ||
| 0.524 | 0.067 | 0.635 | Apoptosis agonist | 0.635 0.042 CID_3385 | CID_3385 | |
| 0.437 | 0.005 | 0.437 | Peptidyltransferase inhibitor | 0.227 0.069 CID_3385 | ||
| 0.492 | 0.085 | 0.492 | DNA directed DNA polymerase inhibitor | |||
| 0.437 | 0.07 | 0.5 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.5 0.034 CID_3385 | CID_3385 | |
| 0.334 | 0.001 | 0.334 | Uridine phosphorylase inhibitor | 0.129 0.002 CID_3385 | ||
| 0.325 | 0.005 | 0.325 | HIV-1 reverse transcriptase inhibitor | 0.151 0.014 CID_3385 | ||
| 0.324 | 0.005 | 0.324 | Antimetabolite | 0.244 0.007 CID_3385 | ||
| 0.323 | 0.009 | 0.323 | UDP-glucose 4-epimerase inhibitor | 0.267 0.012 CID_3385 | ||
| 0.325 | 0.034 | 0.325 | Anticonvulsant | 0.245 0.059 CID_3385 | ||
| 0.367 | 0.133 | 0.367 | Caspase 9 stimulant | 0.289 0.206 CID_3385 | ||
| 0.245 | 0.017 | 0.245 | Alkylator | 0.233 0.019 CID_3385 | ||
| 0.333 | 0.113 | 0.339 | Antibacterial | 0.339 0.108 CID_3385 | CID_3385 | |
| 0.229 | 0.021 | 0.229 | Adenylate cyclase inhibitor | |||
| 0.227 | 0.021 | 0.227 | DNA polymerase I inhibitor | |||
| 0.232 | 0.027 | 0.232 | Interleukin 6 antagonist | |||
| 0.271 | 0.07 | 0.363 | DNA damaging | 0.363 0.037 CID_3385 | CID_3385 | |
| 0.223 | 0.044 | 0.223 | Lipocortins synthesis antagonist | |||
| 0.169 | 0.003 | 0.169 | Thymidylate synthase inhibitor | 0.15 0.003 CID_3385 | ||
| 0.183 | 0.019 | 0.227 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.227 0.012 CID_3385 | CID_3385 | |
| 0.167 | 0.002 | 0.205 | Thymidine phosphorylase inhibitor | 0.205 0.002 CID_3385 | CID_3385 | |
| 0.177 | 0.029 | 0.177 | MAP3K9 inhibitor | |||
| 0.166 | 0.02 | 0.166 | DNA repair enzyme inhibitor | 0.136 0.046 CID_3385 | ||
| 0.208 | 0.066 | 0.208 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.225 | 0.106 | 0.225 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.118 | 0.011 | 0.118 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.104 0.013 CID_3385 | ||
| 0.105 | 0.006 | 0.105 | Thymidine kinase inhibitor | 0.087 0.008 CID_3385 | ||
| 0.1 | 0.019 | 0.1 | Argininosuccinate synthase inhibitor | 0.089 0.022 CID_3385 | ||
| 0.117 | 0.044 | 0.117 | Protein kinase C mu inhibitor | |||
| 0.146 | 0.074 | 0.168 | MAP kinase 3 inhibitor | 0.168 0.045 CID_3385 | CID_3385 | |
| 0.104 | 0.04 | 0.132 | NADH dehydrogenase inhibitor | 0.132 0.023 CID_3385 | CID_3385 | |
| 0.225 | 0.171 | 0.466 | Immunosuppressant | 0.466 0.043 CID_3385 | CID_3385 | |
| 0.192 | 0.146 | 0.192 | MAP kinase kinase 3 inhibitor | |||
| 0.079 | 0.036 | 0.079 | Phosphodiesterase VIII inhibitor | |||
| 0.082 | 0.04 | 0.086 | Phosphofructokinase-1 inhibitor | 0.086 0.038 CID_3385 | CID_3385 | |
| 0.052 | 0.01 | 0.052 | Integrin alpha2 antagonist | 0.038 0.024 CID_3385 | ||
| 0.064 | 0.023 | 0.064 | Phosphorylase inhibitor | 0.057 0.027 CID_3385 | ||
| 0.043 | 0.005 | 0.043 | Integrin alpha2beta1 antagonist | 0.029 0.014 CID_3385 | ||
| 0.041 | 0.005 | 0.041 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.034 0.008 CID_3385 | ||
| 0.048 | 0.011 | 0.048 | Purinergic P2Y2 antagonist | 0.034 0.023 CID_3385 | ||
| 0.076 | 0.041 | 0.076 | HIV-1 integrase inhibitor | |||
| 0.091 | 0.057 | 0.091 | Aminoacyl-tRNA synthetase inhibitor | |||
| 0.068 | 0.036 | 0.09 | Carbamoyl phosphate synthetase inhibitor | 0.09 0.024 CID_3385 | CID_3385 | |
| 0.033 | 0.004 | 0.033 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.028 0.005 CID_3385 | ||
| 0.084 | 0.056 | 0.084 | Acetylcholine M3 receptor agonist | |||
| 0.103 | 0.076 | 0.111 | MAP kinase 13 inhibitor | 0.111 0.066 CID_3385 | CID_3385 | |
| 0.149 | 0.123 | 0.614 | Antimitotic | 0.614 0.007 CID_3385 | CID_3385 | |
| 0.048 | 0.023 | 0.048 | Guanylate cyclase inhibitor | |||
| 0.024 | 0.005 | 0.024 | Purinergic receptor agonist | |||
| 0.024 | 0.005 | 0.024 | Purinergic P2 agonist | |||
| 0.047 | 0.029 | 0.047 | Purinergic P2X4 antagonist | |||
| 0.055 | 0.041 | 0.055 | Adenine nucleotide translocase inhibitor | |||
| 0.019 | 0.005 | 0.019 | Purinergic P2Y agonist | |||
| 0.015 | 0.003 | 0.015 | Purinergic P2Y2 agonist | 0.012 0.005 CID_3385 | ||
| 0.027 | 0.015 | 0.051 | Acid ceramidase inhibitor | 0.051 0.003 CID_3385 | CID_3385 | |
| 0.027 | 0.016 | 0.06 | Calcitonin gene-related peptide antagonist | 0.06 0.006 CID_3385 | CID_3385 | |
| 0.102 | 0.092 | 0.116 | Interleukin 8 antagonist | 0.116 0.067 CID_3385 | CID_3385 | |
| 0.039 | 0.035 | 0.078 | Kainate receptor agonist | 0.078 0.004 CID_3385 | CID_3385 | |
| 0.082 | 0.078 | 0.129 | Thioredoxin inhibitor | 0.129 0.025 CID_3385 | CID_3385 | |
| 0.024 | 0.022 | 0.043 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.043 0.011 CID_3385 | CID_3385 | |
| 0.005 | 0.003 | 0.005 | Purinergic P2Y4 agonist | |||
| 0.003 | 0.002 | 0.003 | Purinergic P2Y6 agonist | |||
| 0.014 | 0.018 | 0.024 | Calcitonin gene-related peptide 1 receptor antagonist | 0.024 0.006 CID_3385 | CID_3385 | |
| 0.05 | 0.054 | 0.126 | Biliverdin reductase inhibitor | 0.126 0.013 CID_3385 | CID_3385 | |
| 0.027 | 0.034 | 0.036 | Fumarate hydratase inhibitor | 0.036 0.022 CID_3385 | CID_3385 | |
| 0.04 | 0.051 | 0.055 | Ornithine carbamoyltransferase inhibitor | 0.055 0.035 CID_3385 | CID_3385 | |
| 0.024 | 0.036 | 0.033 | DNA polymerase III inhibitor | 0.033 0.01 CID_3385 | CID_3385 | |
| 0.061 | 0.076 | 0.111 | Phospholipase D inhibitor | 0.111 0.009 CID_3385 | CID_3385 | |
| 0.046 | 0.063 | 0.126 | Dihydroorotate oxidase inhibitor | 0.126 0.004 CID_3385 | CID_3385 | |
| 0.159 | 0.178 | 0.201 | 5 Hydroxytryptamine 3E antagonist | 0.201 0.06 CID_3385 | CID_3385 | |
| 0.082 | 0.102 | 0.189 | 5 Hydroxytryptamine 3A agonist | 0.189 0.018 CID_3385 | CID_3385 | |
| 0.033 | 0.055 | 0.074 | Glutamate (mGluR group I) agonist | 0.074 0.014 CID_3385 | CID_3385 | |
| 0.046 | 0.076 | 0.084 | Acetylcholine M5 receptor agonist | 0.084 0.031 CID_3385 | CID_3385 | |
| 0.023 | 0.058 | 0.035 | AMPA receptor agonist | 0.035 0.025 CID_3385 | CID_3385 | |
| 0.054 | 0.093 | 0.103 | Secretase beta inhibitor | 0.103 0.017 CID_3385 | CID_3385 | |
| 0.154 | 0.199 | 0.272 | Nitric-oxide synthase stimulant | 0.272 0.02 CID_3385 | CID_3385 | |
| 0.016 | 0.064 | 0.068 | Glutamate (mGluR1) agonist | 0.068 0.004 CID_3385 | CID_3385 | |
| 0.05 | 0.105 | 0.074 | Glutamate dehydrogenase inhibitor | 0.074 0.051 CID_3385 | CID_3385 | |
| 0.106 | 0.162 | 0.166 | GABA C receptor rho-2 antagonist | 0.166 0.055 CID_3385 | CID_3385 | |
| 0.009 | 0.067 | 0.015 | DNA polymerase III polC-type inhibitor | 0.015 0.006 CID_3385 | CID_3385 | |
| 0.008 | 0.074 | 0.021 | Thyroid hormone alpha agonist | 0.021 0.006 CID_3385 | CID_3385 | |
| 0.072 | 0.15 | 0.111 | Adenylate kinase inhibitor | 0.111 0.052 CID_3385 | CID_3385 | |
| 0.012 | 0.091 | 0.049 | Nicotinic acid receptor 2 antagonist | 0.049 0.004 CID_3385 | CID_3385 | |
| 0.022 | 0.104 | 0.068 | Protein kinase (CK2) beta inhibitor | 0.068 0.005 CID_3385 | CID_3385 | |
| 0.069 | 0.158 | 0.097 | Phosphodiesterase 6D inhibitor | 0.097 0.058 CID_3385 | CID_3385 | |
| 0.066 | 0.155 | 0.126 | GABA C receptor antagonist | 0.126 0.046 CID_3385 | CID_3385 | |
| 0.1 | 0.194 | 0.33 | Tumour necrosis factor antagonist | 0.33 0.013 CID_3385 | CID_3385 | |
| 0.048 | 0.145 | 0.116 | Keratolytic | 0.116 0.023 CID_3385 | CID_3385 | |
| 0.023 | 0.13 | 0.052 | AICAR transformylase inhibitor | 0.052 0.02 CID_3385 | CID_3385 | |
| 0.002 | 0.114 | 0.01 | DNA topoisomerase III inhibitor | 0.01 0.004 CID_3385 | CID_3385 | |
| 0.054 | 0.166 | 0.208 | GABA C receptor agonist | 0.208 0.019 CID_3385 | CID_3385 | |
| 0.057 | 0.174 | 0.107 | GABA C receptor rho-1 antagonist | 0.107 0.053 CID_3385 | CID_3385 | |
| 0.037 | 0.154 | 0.058 | Phosphodiesterase 1A inhibitor | 0.058 0.046 CID_3385 | CID_3385 | |
| 0.062 | 0.19 | 0.196 | Alpha-N-acetylglucosaminidase inhibitor | 0.196 0.035 CID_3385 | CID_3385 | |
| 0.041 | 0.171 | 0.08 | Glycine receptor antagonist | 0.08 0.057 CID_3385 | CID_3385 | |
| 0.01 | 0.148 | 0.059 | Nicotinic acid receptor agonist | 0.059 0.011 CID_3385 | CID_3385 | |
| 0.05 | 0.192 | 0.089 | Anabolic | 0.089 0.08 CID_3385 | CID_3385 | |
| 0.007 | 0.158 | 0.028 | Glutamate (mGluR1a) agonist | 0.028 0.01 CID_3385 | CID_3385 | |
| 0.018 | 0.179 | 0.045 | Nicotinic acid receptor 1 agonist | 0.045 0.023 CID_3385 | CID_3385 | |
| 0.024 | 0.185 | 0.047 | Dopamine beta hydroxylase inhibitor | 0.047 0.038 CID_3385 | CID_3385 | |
| 0.044 | 0.209 | 0.254 | Ferrochelatase inhibitor | 0.254 0.013 CID_3385 | CID_3385 | |
| 0.013 | 0.181 | 0.053 | Adenosine A2b receptor antagonist | 0.053 0.031 CID_3385 | CID_3385 | |
| 0.054 | 0.223 | 0.109 | Nav1.1 sodium channel blocker | 0.109 0.056 CID_3385 | CID_3385 | |
| 0.037 | 0.208 | 0.098 | Pim-3 kinase inhibitor | 0.098 0.048 CID_3385 | CID_3385 | |
| 0.097 | 0.284 | 0.204 | Cyclic AMP phosphodiesterase inhibitor | 0.204 0.09 CID_3385 | CID_3385 | |
| 0.044 | 0.231 | 0.111 | Triose-phosphate isomerase inhibitor | 0.111 0.038 CID_3385 | CID_3385 | |
| 0.048 | 0.236 | 0.096 | Electrolyte absorption antagonist | 0.096 0.063 CID_3385 | CID_3385 | |
| 0.107 | 0.296 | 0.139 | Ca2+-transporting ATPase inhibitor | 0.139 0.076 CID_3385 | CID_3385 | |
| 0.016 | 0.206 | 0.068 | Alcohol oxidase inhibitor | 0.068 0.03 CID_3385 | CID_3385 | |
| 0.028 | 0.225 | 0.062 | Pregnane X receptor antagonist | 0.062 0.027 CID_3385 | CID_3385 | |
| 0.029 | 0.233 | 0.069 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.069 0.061 CID_3385 | CID_3385 | |
| 0.019 | 0.228 | 0.052 | Aconitate hydratase inhibitor | 0.052 0.035 CID_3385 | CID_3385 | |
| 0.035 | 0.259 | 0.062 | Glutamate (mGluR6) antagonist | 0.062 0.061 CID_3385 | CID_3385 | |
| 0.027 | 0.255 | 0.058 | Corticotropin releasing factor 2 receptor antagonist | 0.058 0.052 CID_3385 | CID_3385 | |
| 0.018 | 0.246 | 0.075 | Catalase inhibitor | 0.075 0.051 CID_3385 | CID_3385 | |
| 0.127 | 0.357 | 0.212 | Calcium channel activator | 0.212 0.196 CID_3385 | CID_3385 | |
| 0.122 | 0.354 | 0.418 | GABA C receptor rho-3 antagonist | 0.418 0.054 CID_3385 | CID_3385 | |
| 0.016 | 0.252 | 0.069 | Collagenase 3 inhibitor | 0.069 0.032 CID_3385 | CID_3385 | |
| 0.04 | 0.281 | 0.164 | Nav1.6 sodium channel blocker | 0.164 0.04 CID_3385 | CID_3385 | |
| 0.009 | 0.256 | 0.074 | Alpha 1a adrenoreceptor antagonist | 0.074 0.048 CID_3385 | CID_3385 | |
| 0.008 | 0.256 | 0.049 | Nicotinic acid receptor 2 agonist | 0.049 0.014 CID_3385 | CID_3385 | |
| 0.026 | 0.275 | 0.074 | Glutamate (mGluR7) antagonist | 0.074 0.036 CID_3385 | CID_3385 | |
| 0.043 | 0.301 | 0.101 | Interleukin 5 antagonist | 0.101 0.04 CID_3385 | CID_3385 | |
| 0.011 | 0.277 | 0.043 | Histamine H2 receptor agonist | 0.043 0.03 CID_3385 | CID_3385 | |
| 0.025 | 0.293 | 0.11 | Alcohol dehydrogenase inhibitor | 0.11 0.042 CID_3385 | CID_3385 | |
| 0.067 | 0.34 | 0.134 | 3C-like protease (Human coronavirus) inhibitor | 0.134 0.131 CID_3385 | CID_3385 | |
| 0.036 | 0.311 | 0.09 | MAP kinase kinase 1 inhibitor | 0.09 0.071 CID_3385 | CID_3385 | |
| 0.012 | 0.288 | 0.057 | Dihydroorotase inhibitor | 0.057 0.018 CID_3385 | CID_3385 | |
| 0.044 | 0.322 | 0.108 | DOPA decarboxylase inhibitor | 0.108 0.061 CID_3385 | CID_3385 | |
| 0.019 | 0.298 | 0.058 | Dipeptidyl peptidase inhibitor | 0.058 0.029 CID_3385 | CID_3385 | |
| 0.037 | 0.327 | 0.087 | Bromodomain-containing protein 2 inhibitor | 0.087 0.062 CID_3385 | CID_3385 | |
| 0.088 | 0.381 | 0.199 | 5 Hydroxytryptamine release stimulant | 0.199 0.122 CID_3385 | CID_3385 | |
| 0.122 | 0.416 | 0.244 | 5 Hydroxytryptamine uptake stimulant | 0.244 0.087 CID_3385 | CID_3385 | |
| 0.01 | 0.313 | 0.067 | Alpha 1 adrenoreceptor antagonist | 0.067 0.061 CID_3385 | CID_3385 | |
| 0.015 | 0.32 | 0.05 | Dipeptidyl peptidase IV inhibitor | 0.05 0.021 CID_3385 | CID_3385 | |
| 0.053 | 0.359 | 0.292 | Aldehyde oxidase inhibitor | 0.292 0.069 CID_3385 | CID_3385 | |
| 0.015 | 0.322 | 0.08 | Phosphodiesterase III inhibitor | 0.08 0.035 CID_3385 | CID_3385 | |
| 0.048 | 0.358 | 0.098 | CDK3/cyclin E inhibitor | 0.098 0.092 CID_3385 | CID_3385 | |
| 0.026 | 0.338 | 0.088 | Creatine kinase inhibitor | 0.088 0.075 CID_3385 | CID_3385 | |
| 0.06 | 0.377 | 0.148 | Succinate dehydrogenase inhibitor | 0.148 0.115 CID_3385 | CID_3385 | |
| 0.014 | 0.334 | 0.069 | Porphobilinogen synthase inhibitor | 0.069 0.057 CID_3385 | CID_3385 | |
| 0.042 | 0.364 | 0.173 | MAP kinase kinase 2 inhibitor | 0.173 0.102 CID_3385 | CID_3385 | |
| 0.007 | 0.331 | 0.119 | Alpha 1b adrenoreceptor antagonist | 0.119 0.029 CID_3385 | CID_3385 | |
| 0.104 | 0.433 | 0.188 | Tyrosine 3 hydroxylase inhibitor | 0.188 0.158 CID_3385 | CID_3385 | |
| 0.025 | 0.357 | 0.102 | Cystathionine beta-synthase inhibitor | 0.102 0.074 CID_3385 | CID_3385 | |
| 0.042 | 0.375 | 0.123 | Heat shock protein 90 alpha antagonist | 0.123 0.122 CID_3385 | CID_3385 | |
| 0.005 | 0.34 | 0.1 | Alpha 1d adrenoreceptor antagonist | 0.1 0.023 CID_3385 | CID_3385 | |
| 0.06 | 0.398 | 0.128 | CF transmembrane conductance regulator agonist | 0.128 0.124 CID_3385 | CID_3385 | |
| 0.023 | 0.363 | 0.106 | MAP kinase kinase inhibitor | 0.106 0.088 CID_3385 | CID_3385 | |
| 0.041 | 0.39 | 0.174 | Peroxidase inhibitor | 0.174 0.067 CID_3385 | CID_3385 | |
| 0.035 | 0.388 | 0.073 | MDM2 inhibitor | 0.073 0.032 CID_3385 | CID_3385 | |
| 0.033 | 0.388 | 0.19 | Anesthetic general | 0.19 0.08 CID_3385 | CID_3385 | |
| 0.009 | 0.369 | 0.055 | TRPA1 antagonist | 0.055 0.05 CID_3385 | CID_3385 | |
| 0.004 | 0.369 | 0.035 | Methionyl aminopeptidase 1 inhibitor | 0.035 0.018 CID_3385 | CID_3385 | |
| 0.011 | 0.38 | 0.125 | Protein kinase (CK2) inhibitor | 0.125 0.045 CID_3385 | CID_3385 | |
| 0.021 | 0.391 | 0.098 | DNA intercalator | 0.098 0.076 CID_3385 | CID_3385 | |
| 0.063 | 0.438 | 0.208 | Superoxide dismutase inhibitor | 0.208 0.108 CID_3385 | CID_3385 | |
| 0.076 | 0.474 | 0.19 | Insulysin inhibitor | 0.19 0.173 CID_3385 | CID_3385 | |
| 0.006 | 0.408 | 0.064 | Aldose reductase inhibitor | 0.064 0.03 CID_3385 | CID_3385 | |
| 0.023 | 0.426 | 0.066 | Exportin-1 inhibitor | 0.066 0.052 CID_3385 | CID_3385 | |
| 0.069 | 0.48 | 0.142 | Neurotensin receptor agonist | 0.142 0.123 CID_3385 | CID_3385 | |
| 0.025 | 0.441 | 0.086 | HIV-1 integrase (Overall Integration) inhibitor | 0.086 0.069 CID_3385 | CID_3385 | |
| 0.028 | 0.462 | 0.143 | Mannose-6-phosphate isomerase inhibitor | 0.143 0.071 CID_3385 | CID_3385 | |
| 0.025 | 0.49 | 0.102 | Nav1.3 sodium channel blocker | 0.102 0.095 CID_3385 | CID_3385 | |
| 0.083 | 0.573 | 0.268 | 5 Hydroxytryptamine release inhibitor | 0.268 0.203 CID_3385 | CID_3385 | |
| 0.01 | 0.537 | 0.056 | Phosphodiesterase 7A inhibitor | 0.056 0.028 CID_3385 | CID_3385 | |
| 0.037 | 0.624 | 0.204 | Gastrin inhibitor | 0.204 0.142 CID_3385 | CID_3385 | |
| 0.023 | 0.674 | 0.136 | ATPase inhibitor | 0.136 0.128 CID_3385 | CID_3385 | |
| 0.004 | 0.663 | 0.052 | Raf kinase B inhibitor | 0.052 0.048 CID_3385 | CID_3385 | |
| 0.005 | 0.685 | 0.056 | Phosphodiesterase VII inhibitor | 0.056 0.052 CID_3385 | CID_3385 | |
| 0.035 | 0.759 | 0.128 | Growth hormone agonist | 0.128 0.11 CID_3385 | CID_3385 | |
| 0.016 | 0.79 | 0.088 | Phosphodiesterase 7B inhibitor | 0.088 0.073 CID_3385 | CID_3385 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |